Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Daniel Nolan

Pain Medicine Fort Wayne, IN Medical Doctor

NPI 1912084369 CMS profile 958790

608 Union Chapel Rd, Fort Wayne, IN 46845

Open in the dashboard

General payments

$25,870

157 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Daniel Nolan of Fort Wayne, IN is reported in the CMS Open Payments database as having received $25,870 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $237 2
2023 General $191 5
2022 General $4,290 45
2021 General $437 8
2020 General $1,720 20
2019 General $18,995 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Nolan
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Daniel Nolan were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Daniel Nolan Pain Medicine median Middle half National median
2019 $18,995 $498 $126–$1,682 $163
2020 $1,720 $284 $80–$910 $114
2021 $437 $399 $112–$1,219 $132
2022 $4,290 $455 $137–$1,484 $149
2023 $191 $484 $128–$1,495 $160
2024 $237 $498 $131–$1,540 $164
2025 $0 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Medtronic USA, Inc. $17,920 65 payments
  2. Medtronic, Inc. $4,760 54 payments
  3. Abbott Laboratories $2,399 21 payments
  4. Stimwave Technologies Incorporated $379 1 payment
  5. Nevro Corp. $119 1 payment
  6. TerSera Therapeutics LLC $72 4 payments
  7. GRT US Holding, Inc. $45 1 payment
  8. Emergent BioSolutions Inc. $45 1 payment
  9. ASSERTIO THERAPEUTICS, Inc. $29 2 payments
  10. Collegium Pharmaceutical, Inc. $24 2 payments
  11. Other $79 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,604 2 payments
  2. Food and Beverage $7,399 133 payments
  3. Travel and Lodging $4,867 22 payments
Products named General payments · program years 2019–2024
  1. INTELLIS $8,231 14 payments
  2. RESTORE $2,678 39 payments
  3. VANTA ADAPTIVESTIM $2,546 13 payments
  4. Proclaim Family of SCS IPGs $2,000 16 payments
  5. INTELLIS ADAPTIVESTIM $1,796 33 payments
  6. SCS FreedonSpinal Cord Stimulator $379 1 payment
  7. StimQ Peripheral Nerve StimulatorSystem $379 1 payment
  8. SYNCHROMEDII $236 3 payments
  9. SYNCHROMED $197 9 payments
  10. Proclaim IPG $175 2 payments
  11. Other $869 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record